Jerzy Tujakowski

1.7k total citations
9 papers, 378 citations indexed

About

Jerzy Tujakowski is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Jerzy Tujakowski has authored 9 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Jerzy Tujakowski's work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer therapeutics and mechanisms (2 papers). Jerzy Tujakowski is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer therapeutics and mechanisms (2 papers). Jerzy Tujakowski collaborates with scholars based in Poland, United States and Austria. Jerzy Tujakowski's co-authors include Ryszard Oliński, Marek Foksiński, Jean A. Maroun, J McKendrick, Howard A. Burris, A. Wong, P. Koralewski, S. Begbie, Duncan I. Jodrell and Pilar García‐Alfonso and has published in prestigious journals such as Annals of Oncology, International Journal of Cancer and Molecular Pharmacology.

In The Last Decade

Jerzy Tujakowski

9 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jerzy Tujakowski Poland	6	285	80	69	69	54	9	378
Kristin Kaley United States	12	323 1.1×	101 1.3×	77 1.1×	63 0.9×	26 0.5×	36	447
J. W. R. Nortier Netherlands	10	201 0.7×	57 0.7×	32 0.5×	61 0.9×	24 0.4×	16	395
M. González‐Barón Spain	9	213 0.7×	67 0.8×	75 1.1×	35 0.5×	17 0.3×	20	316
E. Kovats Austria	12	408 1.4×	119 1.5×	161 2.3×	34 0.5×	79 1.5×	23	569
Judit Kralovánszky Hungary	15	266 0.9×	98 1.2×	70 1.0×	138 2.0×	25 0.5×	49	511
Luisa Foltran Italy	14	256 0.9×	121 1.5×	68 1.0×	127 1.8×	50 0.9×	40	521
Rosario Dueñas Spain	10	302 1.1×	102 1.3×	29 0.4×	48 0.7×	62 1.1×	19	359
A.B. Benson United States	11	330 1.2×	222 2.8×	222 3.2×	116 1.7×	61 1.1×	29	612
Matthias Ludwig Germany	7	102 0.4×	72 0.9×	41 0.6×	117 1.7×	64 1.2×	10	347
Kyu-pyo Kim South Korea	12	473 1.7×	132 1.6×	268 3.9×	112 1.6×	58 1.1×	18	654

Countries citing papers authored by Jerzy Tujakowski

Since Specialization

Citations

This map shows the geographic impact of Jerzy Tujakowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy Tujakowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy Tujakowski more than expected).

Fields of papers citing papers by Jerzy Tujakowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerzy Tujakowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy Tujakowski. The network helps show where Jerzy Tujakowski may publish in the future.

Co-authorship network of co-authors of Jerzy Tujakowski

This figure shows the co-authorship network connecting the top 25 collaborators of Jerzy Tujakowski. A scholar is included among the top collaborators of Jerzy Tujakowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerzy Tujakowski. Jerzy Tujakowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Rucińska, Monika, Wojciech Rogowski, Marzena Anna Lewandowska, et al.. (2015). CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab. Molecular Diagnosis & Therapy. 19(2). 79–89. 7 indexed citations

Izdebski, Paweł, et al.. (2012). The influence of adjuvant chemotherapy on cognitive functioning of women with breast cancer: a literature review. Nowotwory Journal of Oncology. 62(4). 291–304. 1 indexed citations

Słupski, Maciej, et al.. (2009). Outcomes of simultaneous and delayed resections of synchronous colorectal liver metastases.. PubMed Central. 33 indexed citations

Wojtukiewicz, Marek Z., Ewa Sierko, Elżbieta Starosławska, et al.. (2009). The Polish Cancer Anemia Survey (POLCAS): a retrospective multicenter study of 999 cases. International Journal of Hematology. 89(3). 276–284. 4 indexed citations

Siomek, Agnieszka, Jerzy Tujakowski, Daniel Gackowski, et al.. (2006). Severe oxidatively damaged DNA after cisplatin treatment of cancer patients. International Journal of Cancer. 119(9). 2228–2230. 56 indexed citations

Scheithauer, Werner, J McKendrick, S. Begbie, et al.. (2003). Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Annals of Oncology. 14(12). 1735–1743. 222 indexed citations

Tujakowski, Jerzy, et al.. (2003). A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer. Annals of Oncology. 14(7). 1106–1114. 20 indexed citations

Oliński, Ryszard, Paweł Jaruga, Marek Foksiński, Karol Białkowski, & Jerzy Tujakowski. (1997). Epirubicin-Induced Oxidative DNA Damage and Evidence for Its Repair in Lymphocytes of Cancer Patients Who Are Undergoing Chemotherapy. Molecular Pharmacology. 52(5). 882–885. 34 indexed citations

Jassem, Jacek, et al.. (1993). Low weekly doses of doxorubicin and epidoxorubicin in second line chemotherapy of advanced breast cancer. 22(3). 213–218. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact